hESC-RPE sub-retinal transplant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for hESC-RPE sub-retinal transplant, covering 2024-10-31 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD) [Phase 1, Phase 2]